Trade AstraZeneca ^AZN

GSK's share price is under £22, but with a 'fair value' much higher, is it time for me to buy more right now?

Third View Private Wealth LLC Invests $2.95 Million in Astrazeneca Plc $AZN - Daily Political

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial

Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus

Yousif Capital Management LLC Decreases Stake in Astrazeneca Plc $AZN

GLP-1 Drugs Move Up The Leaderboard As Twin Epidemics Continue To Balloon

ER+/ HER2 - ve Breast Cancer Market Insight, Epidemiology, and Market Forecast Report 2022-2036

Yousif Capital Management LLC Cuts Stake in Astrazeneca Plc $AZN - Daily Political

GSK reports promising early results in ovarian and womb cancer drug trial

Cambiar Investors LLC Has $25.39 Million Stock Position in Astrazeneca Plc $AZN - Markets Daily

Astrazeneca Plc $AZN Shares Bought by Apollon Wealth Management LLC

AstraZeneca HPP Trial Data Tests Rare Disease Growth Expectations

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 54.8% One-Year Surge?

AstraZeneca India to Sell 64-Acre Bengaluru Manufacturing Site for ₹3,400 Crore as Part of Global Strategy, ETPharma

Feasibility of automated AI-based contouring and stable radiomic feature assessment by HyperSight-CBCT Imaging for adaptive high-precision radiotherapy of prostate cancer

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry

AstraZeneca faces China headwinds and key drug launches as two banks back 20% upside

AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group

AstraZeneca (LON:AZN) Price Target Raised to £180

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 55% One-Year Surge?

AstraZeneca India plans to sell 64-acre Bengaluru site for ₹3,400 crore, ETManufacturing

Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer

AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore - The Economic Times

AstraZeneca, Sun Dismiss Patent Suits Over Three Diabetes Drugs

Erste Group Bank Comments on Astrazeneca FY2026 Earnings

Sivik Global Healthcare LLC Makes New Investment in Astrazeneca Plc $AZN

Naviter Wealth LLC Sells 12,014 Shares of Astrazeneca Plc $AZN

£20,000 invested in AstraZeneca shares 5 years ago is now worth…

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

Aurobindo Pharma gets USFDA approval for Dapagliflozin & Metformin XR tablets

Biomarker, treatment patterns, and survival differences in metastatic triple-negative breast cancer by race in the United States

AstraZeneca inks MoU with Telangana for AI-enabled lung cancer screening

Alembic gets FDA nod for Dapagliflozin generic, ETPharma

Astrazeneca (NYSE:AZN) Cut to Hold at Wall Street Zen - Stock Observer

Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight

In the clinic for April 6, 2026 | BioWorld

AstraZeneca's Imfinzi Combines with Lenvatinib to Transform Liver Cancer Treatment, ETPharma

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial

Manufacturing Stocks Worth Watching - April 5th - Daily Political

Aberdeen Group plc Grows Stake in Astrazeneca Plc $AZN

AstraZeneca (AZN) Receives a Buy from Goldman Sachs | Markets Insider

AstraZeneca (LON:AZN) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?

Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer

Astrazeneca (AZN) Rises Higher Than Market: Key Facts

Guggenheim Lifts PT on AstraZeneca PLC (AZN) to 16,500 GBp From 16,000 GBp

AstraZeneca: Imfinzi, Imjudo Combo With Lenvatinib And TACE Show Positive Phase III Trial Results

Deutsche Bank Maintains Sell on AstraZeneca (AZN)

AstraZeneca Rare Disease Data Puts Efzimfotase Alfa In Investor Focus

AstraZeneca's Efzimfotase Data Test Rare Disease Growth Story

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

US bank sees AstraZeneca HPP drug data as supportive of $2.6bn forecast with upside to $4.4bn despite mixed trial results

PFG Private Wealth Management LLC Makes New Investment in Astrazeneca Plc $AZN - Markets Daily

Moody Lynn & Lieberson LLC Increases Holdings in Astrazeneca Plc $AZN

Promising Manufacturing Stocks To Watch Now - March 29th - Markets Daily

PFG Private Wealth Management LLC Invests $297,000 in Astrazeneca Plc $AZN - Stock Observer

AZN: 1H26 Trial Cluster Will Test Sustained Premium Earnings Expectations

Sun Pharmaceuticals Industries Ltd Futures Share Price & Chart Today | IIFL Capital

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2− locally-advanced or metastatic breast cancer

GCC Growth Summit 2026: Can Indian GCCs Effectively Navigate the Challenge of Saying No?, ETGCC

AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results - Update | Morningstar

Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players

Boston Common Asset Management LLC Increases Stock Holdings in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Bought by Allspring Global Investments Holdings LLC

AstraZeneca: Efzimfotase Alfa Shows Positive Results From Phase III Programme

AstraZeneca Drug Candidate Achieves Mixed Results in Trials for Rare Disease | Morningstar

Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC

Author Correction: Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial

Promising Manufacturing Stocks To Watch Today - March 30th

Telnyx package latest hit in PyPI supply-chain compromise • The Register

Tozorakimab trial success hands AstraZeneca a crucial edge in the race to crack COPD's hardest-to-treat patients

Guggenheim Raises AstraZeneca Price Target Ahead of Q1 Earnings

MOR Wealth Management LLC Makes New Investment in Astrazeneca Plc $AZN

MOR Wealth Management LLC Takes $526,000 Position in Astrazeneca Plc $AZN - Markets Daily

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million

Dakota Wealth Management Purchases 5,595 Shares of Astrazeneca Plc $AZN

UK Value Stock Picks Including Serica Energy For Estimated Discount Opportunities

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

A renaissance in targeting the PI3K/AKT/mTOR pathway

Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study

USA Financial Formulas Acquires Shares of 10,063 Astrazeneca Plc $AZN

LVW Advisors LLC Decreases Holdings in Astrazeneca Plc $AZN - Markets Daily

LVW Advisors LLC Sells 3,172 Shares of Astrazeneca Plc $AZN - Stock Observer

USA Financial Formulas Takes Position in Astrazeneca Plc $AZN - Daily Political

Manufacturing Stocks To Add to Your Watchlist - March 28th - Markets Daily

Sax Wealth Advisors LLC Makes New $404,000 Investment in Astrazeneca Plc $AZN - Markets Daily

Nordea Investment Management AB Grows Holdings in Astrazeneca Plc $AZN

AstraZeneca COPD Breakthrough Puts Tozorakimab And Valuation In Sharper Focus

Is AstraZeneca (LSE:AZN) Offering Value After Recent Share Price Pullback

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Market Performance Overview: S&P 500 Rose 1.18%, Earnings Season Q1 2026, Crypto Positive Sentiment

Apple (AAPL) stock overview: Apple Q2 2026 earnings are coming, what to expect on April 30?

Crypto market outlook: South Africa Crypto Market Forecast to Reach $25 Billion by 2033

BTC, ETH, XRP: What’s going on with the top 3 cryptos?

Best crypto brokers in South Africa (2026): Binance, Luno, Coinbase and more

Hormuz Strait Control: Iran's Post-War Maritime Ambitions and Global Repercussions

Global Market Analysis and Geopolitical Shifts: An In-Depth Look

Tesla Stock Plummets Over 5% on Disappointing Q1 Delivery and Production Figures

US Non-Farm Payrolls March Report: Robust Rebound Strengthens Dollar, Fuels Fed Policy Debate

EU Assesses Emergency Measures Amid Long-Term Energy Shock Fears from Middle East Conflict

Iran Claims Downing of US Fighter Jets Amid Heightened Tensions

Oman-Flagged Tankers Navigate Strait of Hormuz, Employing Southern Route

OPEC+ Warns of Long-Term Impact on Energy Assets, Approves Token Production Hike Amidst Strait Blockade